www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release

 << Back



Taro to Announce Full Year Results on May 22, 2019

PDF Version

Earnings Call to Discuss Results to be Conducted Thursday, May 23 at 8:00 am ET

HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 16, 2019-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019.

The Company will conduct an earnings call at 8:00 am ET on Thursday, May 23, 2019, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am ET on Thursday, May 23, 2019)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events
Event     Date and time     Telephone number/ website
Earnings release     May 22, 2019 (AMC)    

www.taro.com
Earnings conference call     May 23, 2019     Participant Toll-Free Dial-In Number: +1 (844) 421-0601
8:00 am ET Participant International Dial-In Number: +1 (716) 247-5800
ID: 8698095
 
            Via audio webcast, details of which will be made available on www.taro.com
Replay of conference call May 23, 2019 to + 1 (855) 859-2056 or +1 (404) 537-3406
May 31, 2019 ID: 8698095
 
           

Via audio webcast playback, details of which will be made available on www.taro.com

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Source: Taro Pharmaceutical Industries Ltd.

Mariano A. Balaguer
VP, CFO
(914) 345-9001
Mariano.Balaguer@taro.com

William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com

Terms of Use		 |
Privacy Statement		 |
Safe Harbor Statement